Oral contraceptives, clotting factors, and thrombosis
- 1 March 1982
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 142 (6) , 758-761
- https://doi.org/10.1016/s0002-9378(16)32484-x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A DOUBLE-BLIND TRIAL TO ASSESS LONG-TERM ORAL ANTICOAGULANT THERAPY IN ELDERLY PATIENTS AFTER MYOCARDIAL INFARCTIONThe Lancet, 1980
- Effect of treatment of hyperlipidaemia on haemostatic variables.BMJ, 1980
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.BMJ, 1980
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980
- Leukostasis in chronic myeloid leukaemia.BMJ, 1978
- HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGENThe Lancet, 1977
- Endotoxin‐Induced Intravascular Coagulation and Shock in Dogs: The Role of Factor VIIBritish Journal of Haematology, 1974
- Hormonal contraception and thromboembolic disease: Effects of the oral contraceptives on hemostatic mechanisms: A review of the literatureJournal of Chronic Diseases, 1971
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970
- An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical AmplifierNature, 1964